PHARMACOKINETICS OF CEFOPERAZONE IN PATIENTS WITH NEOPLASTIC DISEASE

被引：17

作者：

MAKSYMIUK, AW

LEBLANC, BM

BROWN, NS

HO, DH

BODEY, GP

机构：

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1981年 / 19卷 / 06期

关键词：

D O I：

10.1128/AAC.19.6.1037

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：1037 / 1041

页数：5

共 17 条

[1] PHARMACOKINETICS OF CEPHALOSPORINS IN PATIENTS WITH NORMAL OR REDUCED RENAL-FUNCTION [J].

ANDRIOLE, VT .

JOURNAL OF INFECTIOUS DISEASES, 1978, 137 :S88-S99

[2] INVITRO ANTI-MICROBIAL ACTIVITY OF CEFOPERAZONE, CEFOTAXIME, MOXALACTAM (LY127935), AZLOCILLIN, MEZLOCILLIN, AND OTHER BETA-LACTAM ANTIBIOTICS AGAINST NEISSERIA-GONORRHOEAE AND HEMOPHILUS-INFLUENZAE, INCLUDING BETA-LACTAMASE-PRODUCING STRAINS [J].

BAKER, CN ;

THORNSBERRY, C ;

JONES, RN .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (04) :757-761

[3]

BODEY GP, 1976, J ANTIBIOT, V29, P1092, DOI 10.7164/antibiotics.29.1092

[4] CLINICAL-PHARMACOLOGY OF MOXALACTAM IN PATIENTS WITH MALIGNANT DISEASE [J].

ESTEY, EH ;

WEAVER, SS ;

HO, DHW ;

BODEY, GP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (04) :639-644

[5]

GIBALDI M, 1975, PHARMACOKINETICS, P45

[6] INVITRO EVALUATION OF CEFOPERAZONE [J].

HINKLE, AM ;

LEBLANC, BM ;

BODEY, GP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (03) :423-427

[7]

INAGAKI J, 1974, CANCER-AM CANCER SOC, V33, P568, DOI 10.1002/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO

[8]

2-2

[9] SUSCEPTIBILITIES OF ANAEROBIC-BACTERIA TO CEFOPERAZONE AND OTHER ANTIBIOTICS [J].

KAYE, D ;

KOBASA, W ;

KAYE, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (06) :957-960

[10]

KIRBY MM, 1973, J INFECT DIS S, V128, pS341

← 1 2 →